Key terms

About ELAN

Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest ELAN news

Apr 01 8:43am ET Elanco Enhances Board Governance with Strategic Appointments Mar 12 6:47am ET Elanco price target raised to $18 from $12 at Piper Sandler Mar 12 6:36am ET Elanco Animal Health (ELAN) Gets a Hold from Piper Sandler Mar 05 9:40am ET Unusually active option classes on open March 5th Mar 04 8:38am ET Elanco appoints Shiv O’Neill as General Counsel and Corporate Secretary Feb 29 1:13pm ET Elanco responds to Ancora board nominations Feb 29 8:17am ET Ancora nominates four director candidates, urges CEO succession at Elanco Feb 27 7:44am ET Stifel Nicolaus Sticks to Its Buy Rating for Elanco Animal Health (ELAN) Feb 27 5:51am ET Buy Rating Affirmed on Elanco Animal Health Amid Solid FY2024 Guidance and Business Stabilization Feb 27 5:33am ET Elanco price target raised to $19 from $18 at Barclays Feb 27 3:30am ET Analysts Offer Insights on Healthcare Companies: Fate Therapeutics (FATE), Elanco Animal Health (ELAN) and R1 RCM (RCM) Feb 27 1:00am ET Elanco Animal Health’s New Share Price & Shareholder Rights Risk – A Cause for Worry? Feb 26 8:16am ET ELAN Earnings: Elanco Ticks Lower on Mixed Q4 Performance Feb 26 6:31am ET Elanco sees Q1 EPS 25c-28c, consensus 30c Feb 26 6:30am ET Elanco sees FY24 adjusted EPS 87c-95c, consensus 89c Feb 26 6:28am ET Elanco reports Q4 adjusted EPS 8c, consensus 11c Feb 22 5:08am ET Barclays Sticks to Its Buy Rating for Elanco Animal Health (ELAN) Feb 07 6:00am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Elanco Animal Health (ELAN), Hologic (HOLX) and Centene (CNC) Feb 06 5:47am ET Elanco Animal Health (ELAN) Gets a Buy from Barclays Feb 06 4:09am ET Elanco Animal Health Announces Notable Business Transaction Feb 06 4:09am ET Elanco Divests Aqua Business to Intervet for $1.3 Billion Feb 05 10:13am ET M & A News: Merck (NYSE:MRK) Snaps Up Elanco’s (NYSE:ELAN) Aqua Unit for $1.3B Feb 05 6:37am ET Elanco to sell aqua business to Merck for $1.3B in cash Feb 05 6:34am ET Merck Animal Health to acquire Elanco’s aqua business for $1.3B in cash Jan 10 9:10pm ET Analysts Have Conflicting Sentiments on These Healthcare Companies: Staar Surgical (STAA) and Elanco Animal Health (ELAN) Jan 07 8:20pm ET Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN) and Insmed (INSM) Jan 05 5:21am ET Elanco upgraded to Buy from Hold at Stifel Jan 03 1:55pm ET Elanco Animal Health put volume heavy and directionally bearish Jan 02 8:35am ET Elanco names Lawrence Kurzius as next Chairman of the Board

No recent press releases are available for ELAN

ELAN Financials

1-year income & revenue

Key terms

ELAN Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

ELAN Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms